Open AccessA Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis
Author(s) -
Andreas Wollenberg,
Michael Howell,
Emma GuttmanYassky,
Jonathan I. Silverberg,
Claire Birrell,
Christopher Kell,
Koustubh Ranade,
Michelle Dawson,
René van der Merwe
Publication year - 2018
Publication title -
skin the journal of cutaneous medicine
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.28
Subject(s) - atopic dermatitis , dose ranging study , medicine , dermatology , ranging , computer science , alternative medicine , double blind , pathology , placebo , telecommunications
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom